secwatch.observer — SEC 8-K summary
======================================

Issuer:     PepGen Inc. (PEPG)
CIK:        0001835597
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0000950170-25-047690
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PepGen expands board to eight with appointments of Finer and Wyman
------------------------------------------------------------------

- Mitchell Finer (PhD), former CSO at bluebird bio, and Lisa Wyman, CTO at Scholar Rock, join board.
- Board expands from six to eight; Finer Class III director, Wyman Class I director.
- Each receives initial option award of 26,000 shares, vesting over three years.
- Standard non-employee director compensation and indemnification agreements apply.
- CEO cites their expertise in scaling manufacturing and gene therapy development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835597/000095017025047690/0000950170-25-047690-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835597/000095017025047690/pepg-20250327.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-047690

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer